BNP Paribas Financial Markets’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Sell
99,319
-85,380
-46% -$1.15M ﹤0.01% 2900
2025
Q4
$2.07M Sell
184,699
-15,106
-8% -$173K ﹤0.01% 2594
2025
Q3
$2.31M Buy
199,805
+56,131
+39% +$657K ﹤0.01% 2519
2025
Q2
$1.76M Buy
143,674
+49,066
+52% +$617K ﹤0.01% 2563
2025
Q1
$1.36M Buy
94,608
+80,626
+577% +$1.26M ﹤0.01% 2575
2024
Q4
$223K Sell
13,982
-2,911
-17% -$57.6K ﹤0.01% 3801
2024
Q3
$406K Sell
16,893
-6,823
-29% -$156K ﹤0.01% 2949
2024
Q2
$472K Sell
23,716
-29,867
-56% -$582K ﹤0.01% 2694
2024
Q1
$1.07M Buy
53,583
+40,653
+314% +$786K ﹤0.01% 2455
2023
Q4
$290K Buy
12,930
+5,586
+76% +$115K ﹤0.01% 3079
2023
Q3
$148K Sell
7,344
-5,198
-41% -$118K ﹤0.01% 3209
2023
Q2
$321K Sell
12,542
-10,093
-45% -$266K ﹤0.01% 2810
2023
Q1
$673K Buy
22,635
+10,935
+93% +$317K ﹤0.01% 2554
2022
Q4
$317K Sell
11,700
-14,433
-55% -$353K ﹤0.01% 2813
2022
Q3
$569K Sell
26,133
-18,214
-41% -$476K ﹤0.01% 2893
2022
Q2
$1.21M Sell
44,347
-14,696
-25% -$422K ﹤0.01% 2077
2022
Q1
$1.98M Sell
59,043
-20,385
-26% -$657K ﹤0.01% 1822
2021
Q4
$2.75M Buy
79,428
+29,176
+58% +$943K 0.01% 1776
2021
Q3
$1.57M Buy
50,252
+28,706
+133% +$974K ﹤0.01% 2066
2021
Q2
$784K Sell
21,546
-4,116
-16% -$170K ﹤0.01% 2315
2021
Q1
$1.12M Sell
25,662
-408
-2% -$19.1K ﹤0.01% 2077
2020
Q4
$1.2M Sell
26,070
-50,488
-66% -$2.1M ﹤0.01% 1907
2020
Q3
$2.54M Buy
76,558
+2,318
+3% +$74.1K 0.01% 1400
2020
Q2
$2.18M Buy
74,240
+65,881
+788% +$1.91M 0.01% 1460
2020
Q1
$225K Sell
8,359
-1,167
-12% -$34.9K ﹤0.01% 2801
2019
Q4
$321K Buy
9,526
+481
+5% +$17.4K ﹤0.01% 2732
2019
Q3
$339K Buy
9,045
+888
+11% +$33.9K ﹤0.01% 2431
2019
Q2
$356K Sell
8,157
-1,830
-18% -$78.3K ﹤0.01% 2219
2019
Q1
$426K Buy
9,987
+8,841
+771% +$396K ﹤0.01% 2198
2018
Q4
$51.3K Sell
1,146
-5,064
-82% -$265K ﹤0.01% 2697
2018
Q3
$425K Buy
+6,210
New +$400K ﹤0.01% 2090
2018
Q2
Sell
-13,151
Closed -$606K 4422
2018
Q1
$606K Sell
13,151
-13,835
-51% -$657K ﹤0.01% 2072
2017
Q4
$1.25M Buy
26,986
+3,583
+15% +$165K 0.01% 1815
2017
Q3
$1.05M Sell
23,403
-3,692
-14% -$158K ﹤0.01% 1525
2017
Q2
$1.06M Buy
27,095
+14,451
+114% +$546K ﹤0.01% 1501
2017
Q1
$482K Sell
12,644
-7,261
-36% -$283K ﹤0.01% 1756
2016
Q4
$736K Buy
19,905
+6,938
+54% +$248K ﹤0.01% 1482
2016
Q3
$449K Sell
12,967
-15,773
-55% -$552K ﹤0.01% 1274
2016
Q2
$935K Buy
28,740
+25,543
+799% +$782K ﹤0.01% 1207
2016
Q1
$91.8K Sell
3,197
-18,625
-85% -$496K ﹤0.01% 1812
2015
Q4
$729K Sell
21,822
-3,083
-12% -$95.9K ﹤0.01% 1209
2015
Q3
$708K Buy
24,905
+4,301
+21% +$150K ﹤0.01% 1188
2015
Q2
$834K Buy
20,604
+3,442
+20% +$154K ﹤0.01% 1176
2015
Q1
$844K Sell
17,162
-6,726
-28% -$312K ﹤0.01% 1153
2014
Q4
$1.09M Buy
+23,888
New +$939K ﹤0.01% 940

Other funds holding AVNS